The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Tokmachev R.E.

N.N. Burdenko Voronezh State Medical University, Ministry of Health of Russia, Voronezh, Russia

Budnevsky A.V.

N.N. Burdenko Voronezh State Medical University, Ministry of Health of the Russia, Voronezh, Russia

Kravchenko A.Ya.

N.N. Burdenko Voronezh State Medical University, Ministry of Health of Russia, Voronezh, Russia

The role of inflammation in the pathogenesis of chronic heart failure

Authors:

Tokmachev R.E., Budnevsky A.V., Kravchenko A.Ya.

More about the authors

Journal: Therapeutic Archive. 2016;88(9): 106‑110

Read: 2590 times


To cite this article:

Tokmachev RE, Budnevsky AV, Kravchenko AYa. The role of inflammation in the pathogenesis of chronic heart failure. Therapeutic Archive. 2016;88(9):106‑110. (In Russ.)
https://doi.org/10.17116/terarkh2016889106-110

Recommended articles:
Clinical and immu­nological rela­tionships in patients with early schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):35-42
Evaluation of prognostic factors of preterm birth. Russian Journal of Human Reproduction. 2025;(2):37-43
Cyto­kine status of patients with Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):5-12
Myokines — the cardiometabolic risk pote­ntial biomarkers. Russian Journal of Preventive Medi­cine. 2025;(7):119-126

References:

  1. Natsional'nye rekomendatsii po diagnostike i lecheniyu khronicheskoi serdechnoi nedostatochnosti (chetvertyi peresmotr). Serdechnaya nedostatochnost'. 2013;14(7)(81):379-472. (In Russ.) Accessed November 4, 2015. Available at: http://www.scardio.ru/content/Guidelines/SSHF-Guidelines-rev.4.0.1.pdf
  2. Jessup M, Abraham W, Casey D et al. 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation. 2009;119(14):1977-2016. doi:10.1161/circulationaha.109.192064
  3. McMurray J, Adamopoulos S, Anker S et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33(14):1787-1847. doi:10.1093/eurheartj/ehs104
  4. Sumakova I, Yakhontov D. The metabolic status, function of endothelium and morphofuctional parameters of the heart at diastolic heart failure at men of different age categories. Serdechnaya nedostatochnost'. 2010;3:72-75. (In Russ.)
  5. Fomin I. Epidemiologiya khronicheskoi serdechnoi nedostatochnosti v Rossiiskoi Federatsii. In.: Ageev F.T. et al. Khronicheskaya serdechnaya nedostatochnost'. M.: GEOTAR-Media; 2010. (In Russ.)
  6. Kudinova S, Savina N, Gladkikh A et al. Khronicheskaya serdechnaya nedostatochnost' u bol'nykh sakharnym diabetom 2 tipa: osobennosti klinicheskogo techeniya. Kremlevskaya meditsina. Klinicheskii vestnik. 2009;4:46-50. (In Russ.)
  7. Glutkina N, Pyrochkin V. Metabolic syndrome and cardiovascular diseases: pathophysiological aspects. Zhurnal Grodnenskogo gosudarstvennogo meditsinskogo universiteta. 2012;2(38):15-19. (In Russ.)
  8. Tereshchenko S, Dzhaiani N. Angiotensin converting enzyme inhibitors in management of patients with chronic heart failure. Ratsional'naya farmakoterapiya v kardiologii. 2009;5(3):82-88. (In Russ.)
  9. Drapkina O, Palatkina L. New emphases on the study of the pathogenesis of chronic heart failure with preserved ejection fraction: focus on inflammatory markers. Ratsional'naya farmakoterapiya v kardiologii. 2014;10(3):317-321. (In Russ.)
  10. Osipova O, Vlasenko M, Godlevskaya M, Suyazova S. Cytokines in development and advance of the chronic heart failure. Vestnik novyh medicinskih tehnologii. 2012;19(2):322-327. (In Russ.)
  11. Makkonen K, Suyazova S, Osipova O. The maintenance of pro-inflammatory cytokines and C-reactive protein at patients with the chronic heart failure with systolic and diastolic dysfunction of the left ventricle of heart. Fundamental research. 2012;7(1):123-127. (In Russ.)
  12. Belenkov Ju, Tatenkulova S, Mareev V i dr. Vzaimosvjaz' urovnja provospalitel'nyh faktorov s vyrazhennost'ju serdechnoj nedostatochnosti pri ishemicheskoj bolezni serdca. Serdechnaya nedostatochnost′. 2009;10(3):137-139. (In Russ.)
  13. Osipova O, Suyazova S, Serdyukova A et al. Dynamics of proinflammatory cytokines and CRP in patients with chronic heart failure and ischemic heart disease due to drug therapy. Nauchnye vedomosti BelGU. Ser. Med. Farmatsiya. 2012;20:65-70. (In Russ.)
  14. Drapkina O, Palatkina L. Markers of cytokine activation and oxidative stress in patients with chronic heart failure. Serdechnaya nedostatochnost′. 2013;14(6):341-346. (In Russ.)
  15. Orlova V, Khrenov A. Peculiarities of cytokines homeostasis imbalance formaition at patients with chronic pulmonary and chronic heart insufficiency with long-term experience tobacco smoking more than ten years. Tavricheskii mediko-biologicheskii vestnik. 2012;15(57):181-183. (In Russ.)
  16. Kovaleva O. Korrektsiya tsitokinovoi agressii pri serdechnoi nedostatochnosti: teoreticheskie predposylki i prakticheskie realii. Serdechnaya nedostatochnost'. 2011;2:93-100. (In Russ.)
  17. Wedel H, McMurray J, Lindberg M et al. Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide. Eur J Heart Fail. 2009;11(3):281-291.  doi:10.1093/eurjhf/hfn046
  18. Rajendiran KS, Ananthanarayanan RH, Satheesh S et al. Elevated levels of serum sialic acid and high-sensitivity C-reactive protein: markers of systemic inflammation in patients with chronic heart failure. Br J Biomed Scie. 2014;71(1):29-32.
  19. Pall M. The NO/ONOO-Cycle as the Central Cause of Heart Failure. IJMS. 2013;14(11):22274-22330. doi:10.3390/ijms141122274
  20. Belyuk S, Snezhitskii V. Rol' immunnoi aktivatsii i sistemnogo vospaleniya v patogeneze khronicheskoi serdechnoi nedostatochnosti i podkhody k lecheniyu. Zhurnal Grodnenskogo gosudarstvennogo meditsinskogo universiteta. 2010;4:32-35. (In Russ.)
  21. Kostenko V, Ariskina O, Osipova I. Elements of systemic inflammatory response and clinical implications in patients with decompensated chronic heart failure. Sibirskii medicinskii zhurnal. 2014;29(3):37-40. (In Russ.)
  22. Berezikova E, Pustovetova M, Shilov S et al. Tsitokinovyi profil' pri khronicheskoi serdechnoi nedostatochnosti. Patologiya krovoobrashcheniya i kardiokhirurgiya. 2012;3:57-60. (In Russ.)
  23. Panchenko L, Moiseev V, Pirozhkov S et al. Blood Content of Markers of Inflammation and Cytokines in Patients With Alcoholic Cardiomyopathy and Ischemic Heart Disease at Various Stages of Heart Failure. Kardiologiya. 2015;3:41-48. (In Russ.) doi:10.18565/cardio.2015.3.41-48
  24. Chernova S. Soderzhanie provospalitel'nykh tsitokinov i antitel k kollagenu 1-go i 2-go tipa u bol'nykh khronicheskoi serdechnoi nedostatochnost'yu, obuslovlennoi arterial'noi gipertoniei. Terapevt. 2010;6:14-17. (In Russ.)
  25. Mann D. Innate Immunity and the Failing Heart. Circ Res. 2015;116(7):1254-1268. doi:10.1161/circresaha.116.302317
  26. Fontes J, Rose N, Čiháková D. The varying faces of IL-6: From cardiac protection to cardiac failure. Cytokine. 2015;74(1):62-68.  doi:10.1016/j.cyto.2014.12.024
  27. Kuzmin A, Gorbunov V, Goryainova E et al. Changes in the content of some cytokines during chronic heart failure. Kazanskii medicinskii zhurnal. 2012;3:494-498. (In Russ.)
  28. Glezeva N, Voon V, Watson C et al. Exaggerated Inflammation and Monocytosis Associate With Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction: Evidence of M2 Macrophage Activation in Disease Pathogenesis. J Cardiac Fail.. 2015;21(2):167-177.  doi:10.1016/j.cardfail.2014.11.004
  29. Li H, Zhang YY. Roles of proinflammatory cytokines in cardiac remodeling induced by sympathetic nervous/catecholamine. Beijing Da Xue Xue Bao. 2014;46(6):1001-1004. (In Chinese).
  30. Jarrah A, Tarzami S. The duality of chemokines in heart failure. Expert Rev Clin Immunol. 2015;11(4):523-536.  doi:10.1586/1744666x.2015.1024658

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.